ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Trimethylamine-N-oxide (TMAO) promotes balloon injury-induced neointimal hyperplasia via upregulating Beclin1 and impairing flux

Hong, Qingqing; Que, Dongdong; Zhong, Chongbin; Huang, Guanlin; Zhai, Weicheng; Chen, Deshu; Yan, Jing*; Yang, Pingzhen*广州医学院; 南方医科大学
Biomedicine and Pharmacotherapy2022-11DOI: 10.1016/j.biopha.2022.113639
3被引8阅读
引用收藏
分享

摘要

Background and aims: TMAO is a microbiota-dependent metabolite associated with increased risk of various cardiovascular diseases. However, the relationship between TMAO and vascular injury-related neointimal hy-perplasia is unclear. This study aimed to explore whether TMAO promotes neointimal hyperplasia after balloon injury and elucidate the underlying mechanism. Methods and Results: Through hematoxylin and eosin staining and immunohistochemistry staining, we found that supplementary TMAO promoted balloon injury-induced neointimal hyperplasia, while reducing TMAO by antibiotic administration produced the opposite result. TMAO showed limited effect on rat aortic vascular smooth muscle cells (RAOSMCs) proliferation and migration. However, TMAO notably induced dysfunction of rat aortic vascular endothelial cells (RAOECs) in vitro and attenuated reendothelialization of carotid arteries after balloon injury in vivo. Autophagic flux was measured by fluorescent mRFP-GFP-LC3, transmission electron microscopy, and western blot. TMAO impaired autophagic flux, as evidenced by the accumulation of p62 and LC3II and high autophagosome to autolysosome ratios. Furthermore, we confirmed that Beclin1 level increased in TMAO-treated RAOECs and carotid arteries. Knocking down Beclin1 alleviated TMAO-induced autophagic flux impairment and neointimal hyperplasia. Conclusions: TMAO promoted neointimal hyperplasia through Beclin1-induced autophagic flux blockage, sug-gesting that TMAO is a potential target for improvement of vascular remodeling after injury.

学科与关键词

关键词
TMAONeointimal hyperplasiaReendothelializationAutophagic fluxBeclin1
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2022-11
卷期
第 155 卷
页码
113639
DOI
10.1016/j.biopha.2022.113639
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Natural Science Founda- tion of China [82070247, 82000249]; Guangdong Basic and Applied Basic Research Foundation [2019A 1515010899, 2020A1515010288, 2021A1515220101, 2022A151501 2263]

作者

  • H

    Hong, Qingqing (第一作者)

    southern med univ

  • Q

    Que, Dongdong

    southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhong, Chongbin

    southern med univ

  • H

    Huang, Guanlin

    southern med univ

  • Z

    Zhai, Weicheng

    guangzhou med univ

  • C

    Chen, Deshu

    southern med univ

  • Y

    Yan, Jing (通讯)

    southern med univ

  • Y

    Yang, Pingzhen (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417